Current Neuro-Oncology
Volume
24 Number 14
31 July 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 14, 31 July
Hagiwara
A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE,
Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP,
Wick W, Cloughesy TF, Ellingson BM.
Incidence,
molecular characteristics, and imaging features of
"clinically-defined pseudoprogression" in newly
diagnosed glioblastoma treated with chemoradiation.
J
Neurooncol. 2022 Jul 17∟.
doi: 10.1007/s11060-022-04088-3∟.
PMID: 35842871∟.
Observational study˰
ˍ
Thakur
S, Kumar N, Salunke P, Ahuja C, Madan R.
A
Randomized Study of Short Course (One Week) Radiation Therapy with
or without Temozolomide in Elderly and/or Frail Patients with
Newly Diagnosed Glioblastoma (GBM).
Asian
Pac J Cancer Prev. 2022 Jul 17;23(7):2317-2323∟.
doi: 10.31557/APJCP.2022.23.7.2317∟.
PMID: 35901337∟.
Interventional study.
ˍ
Mizuno
R, Homma T, Adachi JI, Mishima K, Suzuki T, Shirahata M, Nishikawa
R, Atushi S.
True
anaplastic oligoastrocytoma with dual genotype: illustrative
case.
J
Neurosurg Case Lessons. 2022 Jul 18;4(3):CASE22146∟.
doi: 10.3171/CASE22146∟.
PMID: 36046704∟.
Case report. ˍ
Kline
C, Jain P, Kilburn L, Bonner ER, Gupta N, Crawford JR, Banerjee A,
Packer RJ, Villanueva-Meyer J, Luks T, Zhang Y, Kambhampati M,
Zhang J, Yadavilli S, Zhang B, Gaonkar KS, Rokita JL, Kraya A,
Kuhn J, Liang W, Byron S, Berens M, Molinaro A, Prados M, Resnick
A, Waszak SM, Nazarian J, Mueller S.
Upfront
biology-guided therapy in diffuse intrinsic pontine glioma:
therapeutic, molecular, and biomarker outcomes from PNOC003.
Clin
Cancer Res. 2022 Jul 19, 2022:CCR-22-0803∟.
doi: 10.1158/1078-0432.CCR-22-0803∟.
PMID: 35852795∟.
Interventional study. ˍ
*
Raschke
F, Witzmann K, Seidlitz A, Wesemann T, Jentsch C, Platzek I, van
den Hoff J, Kotzerke J, Beuthien-Baumann B, Baumann M, Linn J,
Krause M, Troost EGC.
Time-
and dose-dependent volume decreases in subcortical grey matter
structures of glioma patients after radio(chemo)therapy.
Clin
Transl Radiat Oncol. 2022 Jul 20;36:99-105∟.
doi: 10.1016/j.ctro.2022.07.003∟.
PMID: 35965663∟.
Observational study. ˍ
Yogendran
LV, Kalelioglu T, Donahue JH, Ahmad H, Phillips KA, Calautti NM,
Lopes MB, Asthagiri AR, Purow B, Schiff D, Patel SH, Fadul CE.
The
landscape of brain tumor mimics in neuro-oncology practice.
J
Neurooncol. 2022 Jul 20∟.
doi: 10.1007/s11060-022-04087-4∟.
PMID: 35857249∟.
Observational study˰ ˍ
Lin
Z, Yang R, Zheng H, Li Z, Yi G, Wu Q, Yang C, Huang G.
Pleomorphic
xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and
epithelioid glioblastoma: Case series with clinical
characteristics, molecular features and progression
relationship.
Clin
Neurol Neurosurg. 2022 Jul 21;221:107379∟.
doi: 10.1016/j.clineuro.2022.107379∟.
PMID: 35932588∟.
Observational study. ˍ
Luger
AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss
M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F,
Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C,
Fröhling S, Steinbach JP, Ronellenfitsch MW.
Molecular
matched targeted therapies for primary brain tumors-a single
center retrospective analysis.
J
Neurooncol. 2022 Jul 21∟.
doi: 10.1007/s11060-022-04049-w∟.
PMID: 35864412∟.
Observational study. ˍ
Ohno
M, Miyakita Y, Takahashi M, Yanagisawa S, Tamura Y, Narita
Y.
Continuing
maintenance temozolomide therapy beyond 12 cycles confers no
clinical benefit over discontinuation at 12 cycles in patients
with IDH1/2-wildtype glioblastoma.
Jpn
J Clin Oncol. 2022 Jul 21, 2022:hyac114∟.
doi: 10.1093/jjco/hyac114∟.
PMID: 35858227∟.
Observational study˰ ˍ
Todo
T, Ino Y, Ohtsu H, Shibahara J, Tanaka M.
A
phase I/II study of triple-mutated oncolytic herpes virus G47∆
in patients with progressive glioblastoma.
Nat
Commun. 2022 Jul 21;13(1):4119∟.
doi: 10.1038/s41467-022-31262-y∟.
PMID: 35864115∟.
Interventional study. ˍ
*
Todo
T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, Tanaka
M.
Intratumoral
oncolytic herpes virus G47∆ for residual or recurrent
glioblastoma: a phase 2 trial.
Nat
Med. 2022 Jul 21∟.
doi: 10.1038/s41591-022-01897-x∟.
PMID: 35864254∟.
Interventional study. ˍ
Voisin
MR, Zuccato JA, Wang JZ, Zadeh G.
Surgery
for recurrent GBM: a retrospective case-control study.
World
Neurosurg. 2022 Jul 21, 2022:S1878-8750(22)01019-1∟.
doi: 10.1016/j.wneu.2022.07.070∟.
PMID: 35870781∟.
Observational study˰ ˍ
Elserius
ASL, Hodson J, Zisakis A, Ughratdar I.
Is
there a limited value of cytoreductive surgery in elderly patients
with malignant gliomas?
Surg
Neurol Int. 2022 Jul 22;13:320∟.
doi: 10.25259/SNI_438_2022∟.
PMID: 35928314∟.
Observational study. ˍ
Lombardi
F, Augello FR, Artone S, Ayroldi E, Giusti I, Dolo V, Cifone MG,
Cinque B, Palumbo P.
Cyclooxygenase-2
Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In
Extracellular Vesicles Modifying Recipient Cell Phenotype.
Front
Oncol. 2022 Jul 22;12:933746∟.
doi: 10.3389/fonc.2022.933746∟.
PMID: 35936755∟.
Laboratory investigation. ˍ
Muir
M, Traylor JI, Gadot R, Patel R, Prabhu SS.
Repeat
laser interstitial thermal therapy for recurrent primary and
metastatic intracranial tumors.
Surg
Neurol Int. 2022 Jul 22;13:311∟.
doi: 10.25259/SNI_418_2022∟.
PMID: 35928321∟.
Observational study. ˍ
Kamble
AN, Agrawal NK, Koundal S, Bhargava S, Kamble AN, Joyner DA,
Kalelioglu T, Patel SH, Jain R.
Imaging-based
stratification of adult gliomas prognosticates survival and
correlates with the 2021 WHO classification.
Neuroradiology.
2022 Jul 25∟.
doi: 10.1007/s00234-022-03015-7∟.
PMID: 35876874∟.
Observational study˰ ˍ
Pant
I, Chaturvedi S, S Gautam VK, Sarma P, Satti DK.
Extra-axial
adult cerebellopontine angle medulloblastoma: Revisiting a rare
entity.
J
Cancer Res Ther. 2022 Jul 25;18(3):770-773∟.
doi: 10.4103/jcrt.JCRT_675_20∟.
PMID: 35900553∟.
Case report. ˍ
Schepke
E, Löfgren M, Pietsch T, Bontell TO, Kling T, Wenger A, Vega
SF, Danielsson A, Dosa S, Holm S, Öberg A, Nyman P,
Eliasson-Hofvander M, Sandström PE, Pfister SM, Lannering B,
Sabel M, Carén H.
DNA
methylation profiling improves routine diagnosis of paediatric CNS
tumours: a prospective population-based study.
Neuropathol
Appl Neurobiol. 2022 Jul 26, 2022:e12838∟.
doi: 10.1111/nan.12838∟.
PMID: 35892159∟.
Observational study˰ ˍ
Steininger
K, Kahl KH, Konietzko I, Wolfert C, Motov S, Krauß PE,
Bröcheler T, Hadrawa M, Sommer B, Stüben G, Shiban
E.
Intraoperative
radiotherapy during awake craniotomies: preliminary results of a
single-center case series.
Neurosurg
Rev. 2022 Jul 26∟.
doi: 10.1007/s10143-022-01838-9∟.
PMID: 35881316∟.
Observational study. ˍ
Chen
J, Qiu H, Chen R, Huang J, Chen L, Wan J, Chen Q, Zhang
L.
Peritumor
Edema Serves as an Independent Predictive Factor of Recurrence
Patterns and Recurrence-Free Survival for High-Grade
Glioma.
Comput
Math Methods Med. 2022 Jul 27;2022:9547166∟.
doi: 10.1155/2022/9547166∟.
PMID: 35936378∟.
Observational study. ˍ
Chen
J, Kang Z, Li S, Wang C, Zheng X, Cai Z, Pan L, Chen F, Li
W.
Molecular
profile reveals immune-associated markers of medulloblastoma for
different subtypes.
Front
Immunol. 2022 Jul 28;13:911260∟.
doi: 10.3389/fimmu.2022.911260∟.
PMID:
35967388∟.
Laboratory investigation. ˍ
*
Lin
K, Gueble SE, Sundaram RK, Huseman ED, Bindra RS, Herzon
SB.
Mechanism-based
design of agents that selectively target drug-resistant
glioma.
Science.
2022 Jul 28;377(6605):502-511∟.
doi: 10.1126/science.abn7570∟.
PMID: 35901163∟.
Laboratory investigation. ˍ
EndpointsNews∟
ˍ
Gao
S, Jin L, Moliterno J, Corbin ZA, Bindra RS, Contessa JN, Yu JB,
Park HS.
Impact
of radiotherapy delay following biopsy for patients with
unresected glioblastoma.
J
Neurosurg. 2022 Jul 29, 2022:1-11∟.
doi: 10.3171/2022.5.JNS212761∟.
PMID:
35907197∟.
Observational study˰ ˍ
*
Goldman
S, Margol A, Hwang EI, Tanaka K, Suchorska B, Crawford JR, Kesari
S.
Safety
of Tumor Treating Fields (TTFields) therapy in pediatric patients
with malignant brain tumors: Post-marketing surveillance
data.
Front
Oncol. 2022 Jul 29;12:958637∟.
doi: 10.3389/fonc.2022.958637∟.
PMID: 36072789∟.
Observational study. ˍ
Guan
Y, Pan M, Yang J, Lu Q, Han L, Liu Y, Li J, Zhu H, Gong X, Mei G,
Liu X, Pan L, Dai J, Wang Y, Wang E, Wang X.
A
phase II open label, single arm study of hypofractionated
stereotactic radiotherapy with chemoradiotherapy using
intensity-modulated radiotherapy
for newly diagnosed glioblastoma after surgery: the HSCK-010 trial
protocol.
BMC
Cancer. 2022 Jul 29;22(1):827∟.
doi: 10.1186/s12885-022-09914-5∟.
PMID: 35906549∟.
Interventional study. ˍ
Hassel
B, Niehusmann P, Halvorsen B, Dahlberg D.
Pro-inflammatory
cytokines in cystic glioblastoma: A quantitative study with a
comparison with bacterial brain abscesses. With an MRI
investigation
of displacement and destruction of the brain tissue surrounding a
glioblastoma.
Front
Oncol. 2022 Jul 29;12:846674∟.
doi: 10.3389/fonc.2022.846674∟.
PMID: 35965529∟.
Laboratory investigation. ˍ
*
He
X, Zhao W, Huang J, Xu J, Niu S, Zhang Q, Zhang N, Jin H, Shen
G.
Characteristics
and trends of globally registered glioma clinical trials in the
past 16 years.
Ther
Adv Neurol Disord. 2022 Jul 29;15:1–12∟.
doi: 10.1177/17562864221114355∟.
PMID: 35923217∟.
Observational study. ˍ
Stoltze
UK, Foss-Skiftesvik J, van Overeem Hansen T, Byrjalsen A, Sehested
A, Scheie D, Mikkelsen TS, Rasmussen S, Bak M, Okkels H, Callesen
MT, Skjøth-Rasmussen J, Gerdes AM, Schmiegelow K, Mathiasen
R, Wadt K.
Genetic
predisposition & evolutionary traces of pediatric cancer risk:
A prospective 5-year population-based genome sequencing study of
children with CNS tumors.
Neuro
Oncol. 2022 Jul 29, 2022:noac187∟.
doi: 10.1093/neuonc/noac187∟.
PMID: 35902210∟.
Interventional study˰ ˍ
Kim
SM, Lim EJ, Yoo KC, Zhao Y, Kang JH, Lim EJ, Shin I, Kang SG, Lim
HW, Lee SJ.
Glioblastoma-educated
mesenchymal stem-like cells promote glioblastoma infiltration via
extracellular matrix remodelling in the tumour
microenvironment.
Clin
Transl Med. 2022 Jul 31;12(8):e997∟.
doi: 10.1002/ctm2.997∟.
PMID: 35908277∟.
Laboratory investigation. ˍ
*
Venkataramani
V, Yang Y, Schubert MC, Reyhan E, Tetzlaff SK, Wißmann N,
Botz M, Soyka SJ, Beretta CA, Pramatarov RL, Fankhauser L,
Garofano L, Freudenberg A, Wagner J, Tanev DI, Ratliff M, Xie R,
Kessler T, Hoffmann DC, Hai L, Dörflinger Y, Hoppe S, Yabo
YA, Golebiewska A, Niclou SP, Sahm F, Lasorella A, Slowik M,
Döring L, Iavarone A, Wick W, Kuner T, Winkler
F.
Glioblastoma
hijacks neuronal mechanisms for brain invasion.
Cell.
2022 Jul 31;185(16):2899-2917.e31∟.
doi: 10.1016/j.cell.2022.06.054∟.
PMID: 35914528∟.
Laboratory investigation˰ ˍ